Angel Vila-Corcoles

Summary

Affiliation: Hospital Universitari Germans Trias i Pujol
Country: Spain

Publications

  1. ncbi Advances in pneumococcal vaccines: what are the advantages for the elderly?
    Angel Vila-Corcoles
    Department of Public Health, Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    Drugs Aging 24:791-800. 2007
  2. ncbi Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia
    Angel Vila-Corcoles
    Research Unit, Primary Health Care Service of Tarragona Valls, Institut Català de Salut, Tarragona, Spain
    BMC Infect Dis 9:36. 2009
  3. ncbi Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods
    Angel Vila-Corcoles
    Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    Vaccine 25:6699-707. 2007
  4. ncbi Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease
    A Vila-Corcoles
    Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    Int J Clin Pract 62:10-7. 2008
  5. ncbi [EVAN-50 study: Effectiveness of polysaccharide pneumococcus vaccine in preventing pneumococcal infections in the over-50 population]
    Angel Vila Corcoles
    Servicio de Atención Primaria Tarragona Valls, Gerencia de Ambito de Tarragona Terres de l Ebre, Institut Catala de la Salut, Tarragona, Espana
    Aten Primaria 38:299-303. 2006
  6. ncbi Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up
    Angel Vila-Corcoles
    Primary Care Service of Tarragona Valls, EVAN Study Group, Catalonian Health Institute, District of Tarragona, Catalonia, Spain
    BMC Public Health 6:231. 2006
  7. ncbi Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study
    Angel Vila-Corcoles
    Primary Care Service of Tarragona Valls, Catalonian Health Institute, Tarragona, 43001, Spain
    Clin Infect Dis 43:860-8. 2006
  8. ncbi [EQA-17: proposing a synthetic indicator to measure the outcomes of primary care teams in people over 14 years]
    Angel Vila Corcoles
    Servicio de Atención Primaria Tarragona Valls, Gerencia de Ambito Tarragona Terres de l Ebre, Institut Catala de la Salut
    Rev Esp Salud Publica 80:17-26. 2006
  9. ncbi [Coverage and association with clinical variables of antipneumococcal vaccination of the population over 65 years old in Tarragona-Valls]
    Angel Vila Corcoles
    Servicio de Atención Primaria de Tarragona Valls, Institut Catala de la Salut
    Rev Esp Salud Publica 79:645-54. 2005
  10. ncbi [Influenza vaccination and mortality in the elderly]
    Angel Vila-Corcoles
    Servicio de Atención Primaria de Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    Med Clin (Barc) 125:689-91. 2005

Detail Information

Publications26

  1. ncbi Advances in pneumococcal vaccines: what are the advantages for the elderly?
    Angel Vila-Corcoles
    Department of Public Health, Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    Drugs Aging 24:791-800. 2007
    ....
  2. ncbi Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia
    Angel Vila-Corcoles
    Research Unit, Primary Health Care Service of Tarragona Valls, Institut Català de Salut, Tarragona, Spain
    BMC Infect Dis 9:36. 2009
    ..This study assessed current levels of penicillin resistance among Streptococcus Pneumoniae causing pneumonia in Spanish middle age and older adults...
  3. ncbi Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods
    Angel Vila-Corcoles
    Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    Vaccine 25:6699-707. 2007
    ....
  4. ncbi Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease
    A Vila-Corcoles
    Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    Int J Clin Pract 62:10-7. 2008
    ..We assessed the effects of annual influenza vaccination on winter mortality in older adults with COPD...
  5. ncbi [EVAN-50 study: Effectiveness of polysaccharide pneumococcus vaccine in preventing pneumococcal infections in the over-50 population]
    Angel Vila Corcoles
    Servicio de Atención Primaria Tarragona Valls, Gerencia de Ambito de Tarragona Terres de l Ebre, Institut Catala de la Salut, Tarragona, Espana
    Aten Primaria 38:299-303. 2006
    ..To assess the effectiveness of 23-valent polysaccharide vaccine in preventing severe pneumococcal infections in adults over 50 years old...
  6. ncbi Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up
    Angel Vila-Corcoles
    Primary Care Service of Tarragona Valls, EVAN Study Group, Catalonian Health Institute, District of Tarragona, Catalonia, Spain
    BMC Public Health 6:231. 2006
    ..We analysed the evolution of the pneumococcal vaccination rates from 2000 to 2003...
  7. ncbi Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study
    Angel Vila-Corcoles
    Primary Care Service of Tarragona Valls, Catalonian Health Institute, Tarragona, 43001, Spain
    Clin Infect Dis 43:860-8. 2006
    ..However, the effectiveness of the 23-valent PPV remains controversial. We assessed the effectiveness of this vaccine in older adults...
  8. ncbi [EQA-17: proposing a synthetic indicator to measure the outcomes of primary care teams in people over 14 years]
    Angel Vila Corcoles
    Servicio de Atención Primaria Tarragona Valls, Gerencia de Ambito Tarragona Terres de l Ebre, Institut Catala de la Salut
    Rev Esp Salud Publica 80:17-26. 2006
    ..The concept of a synthetic indicator to measure the level of quality of the product generated by the primary care teams could be useful for the improvement of the current evaluation models in primary care services...
  9. ncbi [Coverage and association with clinical variables of antipneumococcal vaccination of the population over 65 years old in Tarragona-Valls]
    Angel Vila Corcoles
    Servicio de Atención Primaria de Tarragona Valls, Institut Catala de la Salut
    Rev Esp Salud Publica 79:645-54. 2005
    ..In Catalonia, a polyanccharide pneumococcal vaccine (PPV) programme which includes subjects over 65 years old, was started in 1999. Three years later, we study the vaccine cover in relation to the presence of risk factors for pneumonia...
  10. ncbi [Influenza vaccination and mortality in the elderly]
    Angel Vila-Corcoles
    Servicio de Atención Primaria de Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    Med Clin (Barc) 125:689-91. 2005
    ..We evaluated the effectiveness of IV in the reduction of mortality in individuals over 65 years of age...
  11. ncbi Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects
    A Vila-Corcoles
    EVAN 65 Group of Primary Care Service Tarragona Valls, Institut Catala de la Salut, Prat de la Riba 39, Tarragona 43001, Spain
    Eur Respir J 26:1086-91. 2005
    ..These findings support the effectiveness of the pneumococcal polysaccharide vaccine to prevent mortality caused by pneumonia in older adults, providing a new argument to recommend systematic vaccination in the elderly...
  12. ncbi Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study
    Olga Ochoa-Gondar
    Research Unit, Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    Vaccine 26:1955-62. 2008
    ..66; 95% CI: 0.43-1.01; p=0.059). Although our findings suggest moderate benefits from the vaccination, the evidence of clinical effectiveness appears limited...
  13. ncbi The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 study
    Olga Ochoa-Gondar
    Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    BMC Public Health 8:222. 2008
    ..However, population-based data are very limited and its overall burden is unclear. This study assessed incidence and mortality from CAP among Spanish community-dwelling elderly...
  14. ncbi Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study
    Angel Vila-Corcoles
    Primary Care Service of Tarragona Valls, EPIVAC Study Group, Institut Catala de la Salut, Prat de la Riba 39, Tarragona 43001, Spain
    Vaccine 27:1504-10. 2009
    ..24; 95% CI: 0.09-0.66). These findings confirm the effectiveness of the vaccine against invasive disease, but they also support the benefit of vaccination in preventing nonbacteremic pneumococcal pneumonia...
  15. ncbi Invasive pneumococcal disease in Catalonian elderly people, 2002-2009: serotype coverage for different anti-pneumococcal vaccine formulations at the beginning of the new conjugate vaccines era
    Angel Vila-Corcoles
    Primary Care Service of Tarragona Valls, Institut Català de Salut, Tarragona, Spain
    Vaccine 29:7430-4. 2011
    ..As main conclusion, in our setting, the PCV-13 has almost similar serotype coverage to the PPV-23 in preventing IPD among the elderly population, which suggests a possible future use of the conjugate vaccine in all age groups...
  16. ncbi Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
    Angel Vila-Corcoles
    Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    BMC Infect Dis 10:73. 2010
    ..However, its efficacy in preventing pneumococcal infections remains controversial. This study assessed the clinical effectiveness of vaccination against invasive pneumococcal disease (IPD) among people over 60 years...
  17. ncbi Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease
    Cinta de Diego
    Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Prat de la Riba 39, Tarragona 43001, Catalonia, Spain
    Eur Heart J 30:209-16. 2009
    ..In this study, we have assessed the effects of annual influenza vaccination on winter mortality in older adults with chronic heart disease...
  18. ncbi Epidemiology of community-acquired pneumonia in older adults: a population-based study
    Angel Vila-Corcoles
    Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Prat de la Riba 39, Tarragona 43001, Spain
    Respir Med 103:309-16. 2009
    ..This study assessed incidence, aetiology, clinical outcomes and risk factors for community-acquired pneumonia (CAP) in older adults...
  19. ncbi Rationale and design of the CAPAMIS study: effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke
    Angel Vila-Corcoles
    Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    BMC Public Health 10:25. 2010
    ..The main objective of this study is to evaluate the clinical effectiveness of PPV-23 in reducing the risk of pneumonia and acute vascular events (related or nonrelated with prior pneumonia) in the general population over 60 years...
  20. ncbi Incidence of invasive pneumococcal disease among elderly people in Southern Catalonia, Spain, 2002-2009: an increase in serotypes not contained in the heptavalent conjugate vaccine
    Olga Ochoa-Gondar
    Primary Care Service of Tarragona Valls, EPIVAC Study Group, Institut Catala de la Salut, Av Prat de la Riba 39, 43001 Tarragona, Spain
    J Infect 63:434-40. 2011
    ..According to these findings, Southern Catalonia region can be classified as a mesoendemic area of pneumococcal infections among elderly people, with a recent increase incidence of some nonPCV7 serotypes (especially 19A)...
  21. ncbi Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up
    Angel Vila-Corcoles
    Primary Care Service of Tarragona, EPIVAC Study Group, Institut Catala de la Salut, Tarragona, Spain
    BMC Public Health 12:222. 2012
    ..abstract:..
  22. ncbi Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination
    Angel Vila-Corcoles
    Department of Public Health, Primary Care Service of Tarragona Valls, Institut Catala de la Salut, Tarragona, Spain
    J Intern Med 266:432-44. 2009
    ..Special attention is given to controversies regarding the efficacy of PPV against pneumonia in adults and its protective effects against myocardial infarction...
  23. ncbi [EVAN-65 project: evaluation of the effectiveness of pneumococcus vaccination in the elderly population over 65]
    A Vila Corcoles
    Medicina de Familia SAP Tarragona Valls, Prat de la Riba 39, 43001 Tarragona, Spain
    Aten Primaria 33:149-53. 2004
    ....
  24. ncbi Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview
    Angel Vila-Corcoles
    Primary Care Service of Tarragona, EPIVAC Study Group, Institut Catala de la Salut, Prat de la Riba 39, 43001, Tarragona, Spain
    Expert Rev Vaccines 11:221-36. 2012
    ..This paper reviews available data on the efficacy and effectiveness of polysaccharide pneumococcal vaccination among adults with chronic respiratory diseases...
  25. ncbi [Usefulness of the CRB-65 scale for prognosis assessment of patients 65 years or older with community-acquired pneumonia]
    Angel Vila Corcoles
    Servicio de Atención Primaria de Tarragona Valls, Dirección de Atención Primaria Camp de Tarragona, Institut Catala de la Salut, Tarragona, Spain
    Med Clin (Barc) 135:97-102. 2010
    ..This study evaluated the ability of the severity rule CRB-65 for the management of older adults with CAP...
  26. ncbi [Incidence and clinical characteristics of community-acquired pneumonia managed as outpatient among elderly people in Tarragona-Valls, Spain]
    Angel Vila Corcoles
    Servicio de Atención Primaria de Tarragona Valls, Dirección de Atención Primaria Camp de Tarragona, Institut Català de la Salut ICS, Tarragona
    Rev Esp Salud Publica 83:321-9. 2009
    ..Few information exists about community-acquired pneumonia (CAP) not hospitalized. This study assessed incidence and clinical characteristics of community-acquired pneumonia (CAP) managed as outpatient among elderly population...